Acadia Pharmaceuticals ACAD
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q1 | 16.61 | 69.44 | 12.10 | 0.11 | 19,290 | 19 |
| 2024Q4 | 18.35 | 95.29 | 13.48 | 0.86 | 153,503 | 144 |
| 2024Q3 | 15.38 | 81.54 | 19.85 | 0.20 | 31,644 | 33 |
| 2024Q2 | 16.25 | 81.86 | 0.20 | 30,437 | 33 | |
| 2024Q1 | 18.49 | 72.42 | 0.10 | 15,210 | 17 | |
| 2023Q4 | 31.31 | 88.01 | 0.28 | 34,944 | 46 | |
| 2023Q3 | 20.84 | 110.80 | -0.39 | -57,776 | -65 | |
| 2023Q2 | 23.95 | 47.88 | 0.01 | 3,037 | 1 | |
| 2023Q1 | 18.82 | 119.24 | -0.27 | -53,584 | -43 | |
| 2022Q4 | 15.92 | 112.65 | -0.26 | -46,063 | -42 | |
| 2022Q3 | 16.36 | 116.85 | -0.17 | -30,866 | -27 | |
| 2022Q2 | 14.09 | 100.25 | -0.21 | -33,651 | -34 | |
| 2022Q1 | 24.22 | 100.40 | -0.70 | -113,016 | -113 | |
| 2021Q4 | 23.34 | 104.08 | -0.27 | -44,657 | -43 | |
| 2021Q3 | 16.61 | 103.46 | -0.09 | -15,301 | -14 | |
| 2021Q2 | 24.39 | 100.72 | -0.27 | -43,709 | -44 | |
| 2021Q1 | 25.80 | 100.52 | -0.42 | -66,772 | -66 | |
| 2020Q4 | 53.46 | 101.23 | -0.42 | -67,162 | -67 | |
| 2020Q3 | 41.25 | 101.23 | -0.54 | -85,899 | -85 | |
| 2020Q2 | 48.47 | 105.42 | -0.26 | -44,010 | -42 |